• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV SYS W/SA 20 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV SYS W/SA 20 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV434-T
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hydrocephalus (3272)
Event Date 08/11/2021
Event Type  malfunction  
Manufacturer Narrative
Additional information/ investigation result will be submitted in a supplemental report.
 
Event Description
It was reported miethke that a progav sys w/sa 20 a.Control reservoir (part # fv434-t) was used during a procedure performed on an unknown date.According to the complainant, when about to place shunt (a progav shuntsystem (fv434-t)), it was found that there was leakage at the edge of reservoir (not at connection).The product was not able to use.Replaced with another one.No patient data available.
 
Manufacturer Narrative
Investigation: visual inspection: the following observations were made during the visual inspection: -no abnormalities (no visible leakage).Permeability test: the test showed that the progav shunt system is permeable.During the test no liquid drained out in an unintended manner.A leakage was not visible.Internal inspection of product: the kink protection was removed for further investigation of the leakage.After removing the kink protection, a leakage under the ligature was visible.Results: based on our investigation results, we can identify a small leakage in the catheter.A possible cause of the leakage could be an excessive pulling and kinking of the catheter during the implantation.As described in the ifu, avoid this during the implantation.At the time of the investigation, it was not clear to us how the mentioned functional impairment occurred.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Event Description
It was reported that a progav 2.0 shuntsystem with a control reservoir (#fv434-t) should be implanted on (b)(6) 2021.According to the complainant,a leakage at the edge of reservoir (not at connection) was detected and the shunt was not able to use.Replaced with another one and the surgery finished succesful.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the procedure.Age: 56 years.Height: 175 cm.Weight: 70 kg.Gender: unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS W/SA 20 A.CONTROL RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key12438653
MDR Text Key270292879
Report Number3004721439-2021-00248
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906130862
UDI-Public4041906130862
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 10/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV434-T
Device Catalogue NumberFV434-T
Device Lot Number20045666
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/16/2021
Initial Date Manufacturer Received 08/13/2021
Initial Date FDA Received09/08/2021
Supplement Dates Manufacturer Received09/28/2021
Supplement Dates FDA Received10/07/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient Weight70
-
-